Biomolecules, Journal Year: 2024, Volume and Issue: 14(11), P. 1410 - 1410

Published: Nov. 6, 2024

Frailty in cirrhosis or advanced chronic liver disease (ACLD) is a relevant prognostic factor. In the present study, we aimed to analyze potential biomarkers associated with frailty and its improvement patients ACLD. We analyzed serum of outpatients ACLD who participated previous study (Román, Hepatol Commun 2024) which was assessed using index (LFI), were frail prefrail randomized multifactorial intervention (home exercise, branched-chain amino acids, probiotics) control for 12 months. determined biomarker battery inflammation, bacterial translocation, damage blood urine metabolomics by

Language: Английский